Skip to main content
. Author manuscript; available in PMC: 2010 Feb 1.
Published in final edited form as: J Clin Virol. 2009 Jan 7;44(2):125–128. doi: 10.1016/j.jcv.2008.11.009

Figure 2. Use of EA in conjunction with ELISA improves the positive predictive value of HSV-2 serodiagnosis compared to EA or ELISA testing alonea.

Figure 2

Estimated positive predictive value for the serodiagnosis of HSV-2 infection when ELISA confirms point-of-care EA results among populations with varying prevalences of HSV-2 infection

a IB used as the standard for performance calculations